COVID-19 disease severity is linked to host immunity as well as lung and gut dysbiosis: a narrative review.

Asai, Nobuhiro; Mikamo, Hiroshige

Asai, Nobuhiro; Mikamo, Hiroshige.

Asai N; Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Aichi, Japan; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
Mikamo H; Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Aichi, Japan. Electronic address: mikamo@aichi-med-u.ac.jp.

J Glob Antimicrob Resist ; 27: 282-283, 2021 12.

Article in English | MEDLINE | ID: covidwho-1500045

Subject(s)

COVID-19; Dysbiosis; Humans; Lung; SARS-CoV-2; Severity of Illness Index

Keywords

COVID-19; Gutlung axis; Lung and gut dysbiosis; Monocyte dysfunction; Pneumonia; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Dysbiosis / COVID-19 Type of study: Prognostic study / Reviews Limits: Humans Language: English Journal: J Glob Antimicrob Resist Year: 2021 Document Type: Article Affiliation country: J.jgar.2021.10.009

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google